Compare DSP & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSP | EBS |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.1M | 303.3M |
| IPO Year | 2021 | 2006 |
| Metric | DSP | EBS |
|---|---|---|
| Price | $11.85 | $5.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $19.32 | $10.00 |
| AVG Volume (30 Days) | 394.1K | ★ 1.1M |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.14 | 125.83 |
| EPS | ★ N/A | N/A |
| Revenue | $344,201,000.00 | ★ $742,900,000.00 |
| Revenue This Year | $26.65 | N/A |
| Revenue Next Year | $21.65 | $7.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $8.72 | $4.36 |
| 52 Week High | $14.80 | $14.06 |
| Indicator | DSP | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 38.19 |
| Support Level | $9.75 | $5.51 |
| Resistance Level | $12.45 | $6.83 |
| Average True Range (ATR) | 0.82 | 0.45 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 28.69 | 15.04 |
Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.